A61K 51/088
Conjugates with carriers being peptides, polyamino acids or proteins
Official title: {conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10)}
A61K51/088 (Conjugates with carriers being peptides, polyamino acids or proteins) appears on 1,001 US grants and 1,414 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,001
- Published applications
- 1,414
- Assignees
- 578
- Inventors
- 2,682
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 9 | 0 |
| 1993 | 8 | 0 |
| 1994 | 8 | 0 |
| 1995 | 10 | 0 |
| 1996 | 16 | 0 |
| 1997 | 22 | 0 |
| 1998 | 43 | 0 |
| 1999 | 41 | 0 |
| 2000 | 26 | 0 |
| 2001 | 25 | 2 |
| 2002 | 14 | 17 |
| 2003 | 12 | 26 |
| 2004 | 11 | 35 |
| 2005 | 7 | 39 |
| 2006 | 27 | 46 |
| 2007 | 15 | 39 |
| 2008 | 13 | 32 |
| 2009 | 21 | 39 |
| 2010 | 14 | 48 |
| 2011 | 28 | 56 |
| 2012 | 32 | 56 |
| 2013 | 42 | 56 |
| 2014 | 50 | 71 |
| 2015 | 43 | 60 |
| 2016 | 47 | 69 |
| 2017 | 38 | 51 |
| 2018 | 41 | 55 |
| 2019 | 41 | 51 |
| 2020 | 41 | 64 |
| 2021 | 34 | 65 |
| 2022 | 37 | 76 |
| 2023 | 50 | 69 |
| 2024 | 30 | 104 |
| 2025 | 39 | 106 |
| 2026 | 41 | 82 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radiopharmaceutical compositions for actinium in targeted radionuclide therapy6 Oct 2026US 12,752,026 B2Curium US LLC
- Compounds comprising a fibroblast activation protein ligand and use thereof15 Sep 2026US 12,734,259 B23B Pharmaceuticals GmbH
- Gastrin-releasing peptide receptor (GRPR)-targeted compounds and uses thereof8 Sep 2026US 12,728,175 B2Alpha-9 Oncology, Inc.
- Radiopharmaceutical compositions for actinium in targeted radionuclide therapy1 Sep 2026US 12,721,912 B2Curium US LLC
- Copper-64 compositions and formulations25 Aug 2026US 12,718,963 B1Curium US LLC
- Radiolabeled compounds targeting the prostate-specific membrane antigen8 Oct 2026US 2026/0306680 A1Provincial Health Services Authority
- Development of a platform to noninvasively image car t cells8 Oct 2026US 2026/0306681 A1Dana-Farber Cancer Institute, Inc.
- Cleavable radioligands for targeting cell surface receptors and uses thereof1 Oct 2026US 2026/0295099 A1Full-Life Technologies UK Limited
- Polypeptide adjuvants and uses thereof24 Sep 2026US 2026/0284209 A1Board of Regents, The University of Texas System
- Radiolabeled activated ester and precursor thereof24 Sep 2026US 2026/0284238 A1Institute of Science Tokyo
Most cited
By later US patents
- Nucleic acid probe linked to a label having a terminal cysteine239US 5,109,124 ABiogen, Inc. · 1992
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Vitamin-targeted imaging agents155US 7,128,893 B2Endocyte, Inc. · 2006
- Stably tethered structures of defined compositions with multiple functions or binding specificities139US 7,521,056 B2IBC Pharmaceuticals, Inc. · 2009
- Multivalent immunoglobulin-based bioactive assemblies139US 7,527,787 B2IBC Pharmaceuticals, Inc. · 2009